| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Dec 10, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 17.5 | -136,112 | -2.46% | ✗ | $4M |
| Dec 4, 2024 | Dec 6, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 17.5 | -138,845 | -2.45% | ✗ | $4.1M |
| Dec 2, 2024 | Dec 4, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 17.5 | -110,933 | -1.92% | ✗ | $3.3M |
| Nov 13, 2024 | Nov 15, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 46.3 | -19,732 | -0.34% | ✓ | $673.7K |
| Oct 18, 2024 | Oct 22, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 17.5 | -13,535 | -15.62% | ✓ | $475.9K |
| Oct 16, 2024 | Oct 18, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 5.0 | -36,684 | -29.75% | ✓ | $1.3M |
| Oct 3, 2024 | Oct 7, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 37.5 | -5,441 | -4.23% | ✓ | $191.1K |
| Oct 1, 2024 | Oct 3, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 15.0 | -29,941 | -18.87% | ✓ | $1.1M |
| Sep 27, 2024 | Oct 1, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 15.0 | -30,974 | -16.33% | ✓ | $1.1M |
| Sep 25, 2024 | Sep 27, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 45.0 | -3,617 | -1.87% | ✓ | $127.1K |
| Sep 20, 2024 | Sep 24, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 5.0 | -120,242 | -38.35% | ✓ | $4.3M |
| Sep 18, 2024 | Sep 20, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 10.0 | -80,293 | -20.39% | ✓ | $2.9M |
| Sep 16, 2024 | Sep 18, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 45.0 | -4,592 | -1.15% | ✓ | $161.2K |
| Sep 5, 2024 | Sep 9, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 48.8 | -1,577 | -0.39% | ✓ | $55.2K |
| Aug 30, 2024 | Sep 4, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 27.5 | -31,300 | -7.26% | ✓ | $1.4M |
| Aug 28, 2024 | Aug 30, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 8.8 | -134,261 | -23.74% | ✓ | $6M |
| Aug 26, 2024 | Aug 28, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 8.8 | -154,900 | -21.50% | ✓ | $7M |
| Aug 22, 2024 | Aug 26, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 8.8 | -180,409 | -20.03% | ✓ | $8.3M |
| Aug 20, 2024 | Aug 22, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 12.5 | -222,603 | -19.81% | ✓ | $10.4M |
| Aug 16, 2024 | Aug 20, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 12.5 | -248,675 | -18.12% | ✓ | $11.3M |
| Aug 14, 2024 | Aug 16, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 12.5 | -281,541 | -17.03% | ✓ | $12.6M |
| Aug 12, 2024 | Aug 14, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 18.8 | -212,477 | -11.39% | ✓ | $9.1M |
| Aug 8, 2024 | Aug 14, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 22.5 | -183,834 | -8.97% | ✓ | $7.9M |
| Aug 8, 2024 | Aug 12, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 35.0 | -183,834 | -2.86% | ✓ | $7.9M |
| Jan 9, 2024 | Jan 11, 2024 | Dyne Therapeutics, Inc. | Director | Buy | 100.0 | +1,714,285 | 27.96% | ✗ | $30M |